Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CCLD
CCLD logo

CCLD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CareCloud Inc (CCLD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.660
1 Day change
-1.12%
52 Week Range
4.010
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CareCloud Inc (CCLD) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the stock has shown some short-term price momentum, the lack of strong positive catalysts, poor financial performance in the latest quarter, and absence of significant trading signals suggest that this is not an optimal entry point for a long-term investment.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 78.107, and moving averages are converging, which does not provide a clear directional signal. The stock is trading near its resistance level (R2: 2.784), which could limit further short-term upside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The open interest put-call ratio of 0.85 suggests a balanced sentiment, while the option volume put-call ratio of 0.15 indicates a higher interest in calls, reflecting mild bullish sentiment.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • The stock has shown a 4.20% increase during the regular market session and a 3.30% gain in post-market trading, indicating short-term momentum. Revenue increased by 8.83% YoY in Q3 2025, and gross margin improved slightly.

Neutral/Negative Catalysts

  • Net income dropped significantly by -354.12% YoY, and EPS declined by -200.00% YoY in Q3 2025, indicating poor profitability. There are no significant trading trends from hedge funds or insiders, no recent news, and no recent congress trading data.

Financial Performance

In Q3 2025, revenue increased by 8.83% YoY to $31,067,000, but net income dropped by -354.12% YoY to $1,695,000. EPS also declined by -200.00% YoY to 0.04. Gross margin improved slightly to 34.83%, up 0.58% YoY. Overall, the financial performance shows revenue growth but significant profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data is available for this stock.

Wall Street analysts forecast CCLD stock price to rise
3 Analyst Rating
Wall Street analysts forecast CCLD stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.690
sliders
Low
3.25
Averages
6.42
High
8
Current: 2.690
sliders
Low
3.25
Averages
6.42
High
8
ThinkEquity
NULL -> Buy
initiated
$8
AI Analysis
2025-11-24
Reason
ThinkEquity
Price Target
$8
AI Analysis
2025-11-24
initiated
NULL -> Buy
Reason
ThinkEquity initiated coverage of CareCloud with a Buy rating and $8 price target.
Roth Capital
Richard Baldry
Neutral
upgrade
2025-11-06
Reason
Roth Capital
Richard Baldry
Price Target
2025-11-06
upgrade
Neutral
Reason
Roth Capital analyst Richard Baldry raised the firm's price target on CareCloud to $3.25 from $2.25 and keeps a Neutral rating on the shares. The firm upped estimates post the Q3 report. Cost controls and cuts will extend CareCloud's adjusted EBITDA in the near-term, the analyst tells investors in a research note. Roth cites the company's "flattening" revenue and EBITDA outlook for its hold rating.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CCLD
Unlock Now

People Also Watch